Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

58
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
58

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photobiomodulation Therapy in the Management of Orofacial Neuropathic Pain-WALT Position Paper 2026.

Journal of clinical medicine·2026
Same author

4-Methylumbelliferone (4-MU) Improves Learning and Memory After Cerebral Ischemia/Reperfusion Injury in Rats.

Behavioural neurology·2025
Same author

Porous Silicon Nanoparticle Hydrogel Formulation for Topical Delivery of Flightless I Neutralizing Antibody and Improved Diabetic Wound Healing.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Functional Recovery Promotion After Spinal Cord Injury With Astaxanthin Treatment in Preclinical Studies: A Systematic Review and Meta-Analysis.

Neurology research international·2025
Same author

Micro-Focused Ultrasound Technology for Remodeling of Skin Tissue Architecture in an Animal Model.

Lasers in surgery and medicine·2025
Same author

The Role of Artificial Intelligence in Photomedicine.

Photobiomodulation, photomedicine, and laser surgery·2025

Related Experiment Video

Updated: Mar 7, 2026

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

1.6K

Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light.

Mahdi Karimi1, Parham Sahandi Zangabad2,3,4, Soodeh Baghaee-Ravari5

  • 1Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts 02114, United States.

Journal of the American Chemical Society
|February 14, 2017
PubMed
Summary

Smart nanocarriers activated by light offer advanced biomedical applications. These light-triggered drug delivery systems (DDSs) promise enhanced therapies for diseases like cancer with fewer side effects.

More Related Videos

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
11:20

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation

Published on: August 30, 2017

7.9K
A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles
12:51

A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles

Published on: November 14, 2015

10.5K

Related Experiment Videos

Last Updated: Mar 7, 2026

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

1.6K
An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
11:20

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation

Published on: August 30, 2017

7.9K
A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles
12:51

A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles

Published on: November 14, 2015

10.5K

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Nanotechnology

Background:

  • Nanoparticles are revolutionizing biomedical applications, including biosensing and targeted drug delivery.
  • Smart nanocarriers responding to environmental stimuli are a rapidly advancing area in drug delivery systems (DDSs).

Purpose of the Study:

  • To explore the potential of light-activated nanoplatforms for various photoactivated therapies and drug delivery systems.
  • To highlight the role of light as a trigger for enhanced and synergistic therapeutic approaches.

Main Methods:

  • Utilizing light-responsive mechanisms such as photoisomerization, photo-cross-linking, and photoreduction in nanocarriers.
  • Employing nonlinear light absorption mechanisms like two-photon absorption and photon upconversion for DDS design.
  • Integrating light stimuli into multiresponsive nanocarriers for spatiotemporal control.

Main Results:

  • Light-activated DDSs enable precise control over therapeutic agent release and targeted delivery.
  • Applications include photodynamic therapy, photothermal therapy, anticancer drug delivery, and theranostics.
  • Combined light-responsive approaches can lead to enhanced therapeutic efficacy.

Conclusions:

  • Light-activated nanomedicines and DDSs offer a promising avenue for treating complex diseases like cancer, inflammation, and cardiovascular conditions.
  • These advanced systems aim to improve therapeutic effectiveness while minimizing adverse side effects.
  • The development of light-responsive nanocarriers is paving the way for novel patient treatments worldwide.